Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2016-04-25 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaktioner i forbindelse med Novozymes’ aktietilbagekøbsprogram
Transaction in Own Shares Classification · 100% confidence The document details specific transactions related to Novozymes' stock buyback program, including the number of shares purchased, average prices, and the total value of treasury shares. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchases.
2016-04-25 English
Delårsrapport for 1. kvartal 2016
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim report for the first three months of 2016' and contains detailed financial statements, performance analysis, and outlook data for the specified period. It is clearly a comprehensive quarterly financial report rather than a brief announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-04-20 English
Delårsrapport for 1. kvartal 2016
Earnings Release Classification · 90% confidence The document is a concise summary of first quarter financial performance (sales growth, EBIT, net profit, cash flow, outlook) with executive commentary, typical of an earnings announcement press release. It does not include full financial statements or detailed notes, so it fits the "Earnings Release (ER)" category rather than a comprehensive interim report. Q1 2016
2016-04-20 English
Delårsrapport for 1. kvartal 2016
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for the first quarter of 2016 for Novozymes A/S. It contains comprehensive financial statements, detailed analysis of business segments, geographic performance, cash flow, balance sheet data, and sustainability metrics. It is a substantive financial report for a period shorter than a full fiscal year, not merely an announcement or certification. Therefore, it fits the definition of an Interim/Quarterly Report. Q1 2016
2016-04-20 English
Delårsrapport for 1. kvartal 2016
Earnings Release Classification · 92% confidence The text is a press release announcing first quarter financial results (organic sales growth, operating profit, margins, free cash flow) along with management commentary and full‐year outlook guidance. It does not include full financial statements but provides key performance highlights. This aligns with an initial Earnings Release. Q1 2016
2016-04-20 Danish
Transaction in Own Shares 2016
Transaction in Own Shares Classification · 99% confidence The document explicitly details transactions made under a 'stock buyback program,' providing specific dates, number of shares purchased, average prices, and total transaction values. This directly relates to the company repurchasing or selling its own shares. According to the definitions, 'Transaction in Own Shares (Code: POS)' covers 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. The document is a specific report detailing these transactions, not just an announcement of a report (RPA) or a general regulatory filing (RNS).
2016-04-18 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.